Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neoplasms, Neuroepithelial 1 Mucositis 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Head and Neck Neoplasms 1 Exanthema 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

benralizumab 1 Sirolimus 1 Gels 1 Fulvestrant 1 Fibroblast Growth Factor 7 1 Dapsone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Exanthema × Fibroblast Growth Factor 7 × Clear all

NCT00610818 2008-02-08

Palifermin

McGill University Health Centre/Research Institute of the McGill University Health Centre

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡